These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Auditory results after vestibular nerve section and intratympanic gentamicin for Ménière's disease. Colletti V, Carner M, Colletti L. Otol Neurotol; 2007 Feb; 28(2):145-51. PubMed ID: 17255880 [Abstract] [Full Text] [Related]
3. Long-term hearing outcome in patients receiving intratympanic gentamicin for Ménière's disease. Wu IC, Minor LB. Laryngoscope; 2003 May; 113(5):815-20. PubMed ID: 12792316 [Abstract] [Full Text] [Related]
4. Intratympanic gentamicin for intractable Meniere's disease. Perez N, Martín E, García-Tapia R. Laryngoscope; 2003 Mar; 113(3):456-64. PubMed ID: 12616197 [Abstract] [Full Text] [Related]
5. Hearing results following intratympanic gentamicin perfusion for Ménière's disease. Kyrodimos E, Aidonis I, Sismanis A. J Laryngol Otol; 2009 Apr; 123(4):379-82. PubMed ID: 18954493 [Abstract] [Full Text] [Related]
6. Continuous intratympanic infusion of gentamicin via a microcatheter in Menière's disease. Schoendorf J, Neugebauer P, Michel O. Otolaryngol Head Neck Surg; 2001 Feb; 124(2):203-7. PubMed ID: 11226958 [Abstract] [Full Text] [Related]
8. Vestibular nerve section versus intratympanic gentamicin for Meniere's disease. Hillman TA, Chen DA, Arriaga MA. Laryngoscope; 2004 Feb; 114(2):216-22. PubMed ID: 14755193 [Abstract] [Full Text] [Related]
9. Intratympanic gentamicin treatment in Meniere's disease: patients' experiences and outcomes. Smith WK, Sandooram D, Prinsley PR. J Laryngol Otol; 2006 Sep; 120(9):730-5. PubMed ID: 16848921 [Abstract] [Full Text] [Related]
10. Vestibular and audiologic functions in gentamicin-treated Menière's disease. Möller C, Odkvist LM, Thell J, Larsby B, Hydén D. Am J Otol; 1988 Sep; 9(5):383-91. PubMed ID: 3202127 [Abstract] [Full Text] [Related]
11. [Intratympanic gentamicin treatment for intractable Menière's disease]. Gilony D, Wolf M, Kronenberg J. Harefuah; 2004 Jan; 143(1):4-7, 88. PubMed ID: 14748278 [Abstract] [Full Text] [Related]
12. Factors relating to the vertigo control and hearing changes following intratympanic gentamicin for intractable Ménière's disease. Horii A, Saika T, Uno A, Nishiike S, Mitani K, Nishimura M, Kitahara T, Fukushima M, Nakagawa A, Masumura C, Sasaki T, Kizawa K, Kubo T. Otol Neurotol; 2006 Sep; 27(6):896-900. PubMed ID: 16788414 [Abstract] [Full Text] [Related]
16. Long-term disability of class A patients with Ménière's disease after treatment with intratympanic gentamicin. Boleas-Aguirre MS, Sánchez-Ferrandiz N, Guillén-Grima F, Perez N. Laryngoscope; 2007 Aug; 117(8):1474-81. PubMed ID: 17607149 [Abstract] [Full Text] [Related]
18. Intratympanic gentamicin injection for the treatment of Meniere's disease. Youssef TF, Poe DS. Am J Otol; 1998 Jul; 19(4):435-42. PubMed ID: 9661751 [Abstract] [Full Text] [Related]
19. Treatment of intractable Menière's disease with intratympanic gentamicin: review of the University of Ottawa experience. Corsten M, Marsan J, Schramm D, Robichaud J. J Otolaryngol; 1997 Dec; 26(6):361-4. PubMed ID: 9438932 [Abstract] [Full Text] [Related]
20. Treatment of Ménière's disease by low-dosage intratympanic gentamicin application: effect on otolith function. Helling K, Schönfeld U, Clarke AH. Laryngoscope; 2007 Dec; 117(12):2244-50. PubMed ID: 17909448 [Abstract] [Full Text] [Related] Page: [Next] [New Search]